 COPENHAGEN, Denmark, Nov. 02, 2020 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to address unmet medical needs, today announced that the company will hold a conference call and live webcast on Wednesday, November 11, 2020 at 4:30 p.m. Eastern Time ET to review its third quarter 2020 financial results and provide a business update. 